Name of License: Notice of Intent to Grant an Exclusive License to Apex
Summary: Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to offer to Apex Foot Health Industries, 400 Frank W. Burr Blvd. Suite #240, Teaneck, NJ 07666, an exclusive license to VA’s rights in US Patent Nos. 10,292,452 and 10,779,612 and all foreign counterparts, associated with VA Invention Disclosure number 2015-060 titled, “Rocker Shoe Development Kit”.
Tech Name:
Rocker Shoe Development Kit
Dates: Comments must be received on or before August 31, 2021
Address: Send comments to Mr. Ryan Davis, Technology Transfer Specialist, Office of Research and Development (10X2TT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 632-7554 (this is not a toll-free number), [email protected].
For Further Information Contact: Send comments to Mr. Ryan Davis, Technology Transfer Specialist, Office of Research and Development (10X2TT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 632-7554 (this is not a toll-free number), [email protected].
Supplementary Information: The Federal Government’s patent rights in this invention are assigned to the US Government as represented by the Department of Veterans Affairs. It is in the public interest to license this invention as the license will comply with the requirement to submit a complete and sufficient application for a license prior to execution of a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development, Technology Transfer Program receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.